J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 76 (1995), 3099-3106; DOI 10.1099/0022-1317-76-12-3099
© 1995 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanno, T.
Right arrow Articles by Yamaguchi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanno, T.
Right arrow Articles by Yamaguchi, S.
Agricola
Right arrow Articles by Kanno, T.
Right arrow Articles by Yamaguchi, S.

Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants

Toru Kanno1, Toru Inoue1, Yifei Wang2, Akinori Sarai2 and Shigeo Yamaguchi1,*

1 Exotic Diseases Research Division, National Institute of Animal Health, Josuihoncho, Kodaira-shi, Tokyo 187
and2 Tsukuba Life Science Center, The Institute of Physical and Chemical Research (RIKEN), Koyadai, Tsukuba, Ibaraki 305, Japan

Neutralization sites on swine vesicular disease virus (SVDV) have been identified by sequence analysis of neutralization-resistant mutants. Eight neutralizing monoclonal antibodies (MAbs) were produced and neutralization-resistant mutants were selected with the MAbs. Resistance of the mutants to neutralization was shown using the stab-neutralization method, and the results indicated the presence of five neutralization sites on the virus. The location of each site was identified from amino acid changes resulting from nucleotide substitutions in the mutants, and designated site 1 (residues 87 and 88 of VP1), 2a (residue 163 of VP2), 2b (residue 154 of VP2), 3a (residues 272 and 275 of VP1, 60 of VP3) and 3b (residues 70 and 233 of VP2, 73 and 76 of VP3). The locations of the amino acid substitutions at each site formed a cluster on a computer-simulated three-dimensional model of SVDV and were exposed to the surface of the virion.

* Author for correspondence. Fax +81 423 25 5122.

Received 15 March 1995; accepted 28 July 1995.


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
S.-Q. Sun, X.-T. Liu, H.-C. Guo, S.-H. Yin, Y.-J. Shang, X. Feng, Z.-X. Liu, and Q.-G. Xie
Protective immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus
J. Gen. Virol., March 1, 2007; 88(3): 842 - 848.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
Y.-J. Ko, K.-S. Choi, J.-J. Nah, D. J. Paton, J.-K. Oem, G. Wilsden, S.-Y. Kang, N.-I. Jo, J.-H. Lee, J.-H. Kim, et al.
Noninfectious Virus-Like Particle Antigen for Detection of Swine Vesicular Disease Virus Antibodies in Pigs by Enzyme-Linked Immunosorbent Assay
Clin. Vaccine Immunol., August 1, 2005; 12(8): 922 - 929.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Verdaguer, M. A. Jimenez-Clavero, I. Fita, and V. Ley
Structure of Swine Vesicular Disease Virus: Mapping of Changes Occurring during Adaptation of Human Coxsackie B5 Virus To Infect Swine
J. Virol., September 15, 2003; 77(18): 9780 - 9789.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. E. Fry, N. J. Knowles, J. W. I. Newman, G. Wilsden, Z. Rao, A. M. Q. King, and D. I. Stuart
Crystal Structure of Swine Vesicular Disease Virus and Implications for Host Adaptation
J. Virol., May 1, 2003; 77(9): 5475 - 5486.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
B. Borrego, J. A. Garcia-Ranea, A. Douglas, and E. Brocchi
Mapping of linear epitopes on the capsid proteins of swine vesicular disease virus using monoclonal antibodies
J. Gen. Virol., June 1, 2002; 83(6): 1387 - 1395.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
B. Borrego, E. Carra, J. A. Garcia-Ranea, and E. Brocchi
Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus
J. Gen. Virol., January 1, 2002; 83(1): 35 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. A. Jiménez-Clavero, E. Escribano-Romero, A. J. Douglas, and V. Ley
The N-Terminal Region of the VP1 Protein of Swine Vesicular Disease Virus Contains a Neutralization Site That Arises upon Cell Attachment and Is Involved in Viral Entry
J. Virol., January 15, 2001; 75(2): 1044 - 1047.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
J. M. J. Rebel, C. H. Leendertse, A. Dekker, F. van Poelwijk, and R. J. M. Moormann
Construction of a full-length infectious cDNA clone of swine vesicular disease virus strain NET/1/92 and analysis of new antigenic variants derived from it
J. Gen. Virol., November 1, 2000; 81(11): 2763 - 2769.
[Abstract] [Full Text]


Home page
J. Virol.Home page
T. Kanno, D. Mackay, T. Inoue, G. Wilsden, M. Yamakawa, R. Yamazoe, S. Yamaguchi, J. Shirai, P. Kitching, and Y. Murakami
Mapping the Genetic Determinants of Pathogenicity and Plaque Phenotype in Swine Vesicular Disease Virus
J. Virol., April 1, 1999; 73(4): 2710 - 2716.
[Abstract] [Full Text]


Home page
J. Gen. Virol.Home page
S. Nijhar, D. Mackay, E Brocchi, N. Ferris, R. Kitching, and N. Knowles
Identification of neutralizing epitopes on a European strain of swine vesicular disease virus
J. Gen. Virol., February 1, 1999; 80(2): 277 - 282.
[Abstract]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1995 by the Society for General Microbiology.